347 related articles for article (PubMed ID: 9129011)
1. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura.
Furlan M; Robles R; Solenthaler M; Wassmer M; Sandoz P; Lämmle B
Blood; 1997 May; 89(9):3097-103. PubMed ID: 9129011
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of von Willebrand factor-cleaving protease in familial and acquired thrombotic thrombocytopenic purpura.
Furlan M; Lämmle B
Baillieres Clin Haematol; 1998 Jun; 11(2):509-14. PubMed ID: 10097823
[TBL] [Abstract][Full Text] [Related]
3. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B
N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245
[TBL] [Abstract][Full Text] [Related]
4. Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura.
Furlan M; Robles R; Solenthaler M; Lämmle B
Blood; 1998 Apr; 91(8):2839-46. PubMed ID: 9531594
[TBL] [Abstract][Full Text] [Related]
5. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
Furlan M; Lämmle B
Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
[TBL] [Abstract][Full Text] [Related]
6. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP).
Gerritsen HE; Turecek PL; Schwarz HP; Lämmle B; Furlan M
Thromb Haemost; 1999 Nov; 82(5):1386-9. PubMed ID: 10595623
[TBL] [Abstract][Full Text] [Related]
7. Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura.
Furlan M; Robles R; Morselli B; Sandoz P; Lämmle B
Thromb Haemost; 1999 Jan; 81(1):8-13. PubMed ID: 10348715
[TBL] [Abstract][Full Text] [Related]
8. Autosomal recessive inheritance of von Willebrand factor-cleaving protease deficiency.
te Loo DM; Levtchenko E; Furlan M; Roosendaal GP; van den Heuvel LP
Pediatr Nephrol; 2000 Aug; 14(8-9):762-5. PubMed ID: 10955922
[TBL] [Abstract][Full Text] [Related]
9. [Measurement of plasma von Willebrand factor cleaving protease in patients with varied thrombotic microangiopathy].
Katagiri H; Kawai Y; Sugizaki N; Sakai K; Handa M; Okamoto S; Watanabe K
Rinsho Byori; 2003 Jun; 51(6):516-21. PubMed ID: 12884737
[TBL] [Abstract][Full Text] [Related]
10. von Willebrand factor and thrombotic thrombocytopenic purpura.
Raife TJ; Montgomery RR
Curr Opin Hematol; 2000 Sep; 7(5):278-83. PubMed ID: 10961577
[TBL] [Abstract][Full Text] [Related]
11. Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome.
Moake JL
Arch Pathol Lab Med; 2002 Nov; 126(11):1430-3. PubMed ID: 12421153
[TBL] [Abstract][Full Text] [Related]
12. von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.
Moake JL
Semin Hematol; 2004 Jan; 41(1):4-14. PubMed ID: 14727254
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of von Willebrand factor-cleaving protease activity in patients with thrombotic thrombocytopenic purpura.
Gao WQ; Su J; Bai X; Wang ZY; Ruan CG
Chin Med J (Engl); 2004 Jun; 117(6):818-22. PubMed ID: 15198879
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.
Tsai HM; Lian EC
N Engl J Med; 1998 Nov; 339(22):1585-94. PubMed ID: 9828246
[TBL] [Abstract][Full Text] [Related]
15. Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity.
Mori Y; Wada H; Gabazza EC; Minami N; Nobori T; Shiku H; Yagi H; Ishizashi H; Matsumoto M; Fujimura Y
Transfusion; 2002 May; 42(5):572-80. PubMed ID: 12084165
[TBL] [Abstract][Full Text] [Related]
16. Decreased levels of von Willebrand factor-cleaving protease in coronary heart disease and thrombotic thrombocytopenic purpura: study of a simplified method for assaying the enzyme activity based on ristocetin-induced platelet aggregation.
Yoo G; Blombäck M; Schenck-Gustafsson K; He S
Br J Haematol; 2003 Apr; 121(1):123-9. PubMed ID: 12670342
[TBL] [Abstract][Full Text] [Related]
17. von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP.
Schneppenheim R; Budde U; Oyen F; Angerhaus D; Aumann V; Drewke E; Hassenpflug W; Häberle J; Kentouche K; Kohne E; Kurnik K; Mueller-Wiefel D; Obser T; Santer R; Sykora KW
Blood; 2003 Mar; 101(5):1845-50. PubMed ID: 12393505
[TBL] [Abstract][Full Text] [Related]
18. Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases.
Veyradier A; Obert B; Houllier A; Meyer D; Girma JP
Blood; 2001 Sep; 98(6):1765-72. PubMed ID: 11535510
[TBL] [Abstract][Full Text] [Related]
19. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
Moake JL; McPherson PD
Am J Med; 1989 Sep; 87(3N):9N-15N. PubMed ID: 2486537
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
